Surgical Approach Including Hyperthermic Intraperitoneal Chemotherapy (HIPEC) in Patients with Peritoneal Metastasis

URN to cite this document:: urn:nbn:de:bvb:355-epub-408817
DOI to cite this document:: 10.5283/epub.40881

Glockzin, Gabriel ; Piso, Pompiliu ; Schlitt, Hans J.

Preview

PDF - Published Version
(588kB)

Date of publication of this fulltext: 22 Oct 2019 11:24

Alternative links to fulltext:DOI Publisher

Details

Preview

Export bibliographical data

Abstract

Background: Peritoneal metastasis arising from colorectal cancer, appendiceal cancer, gastric cancer and gynecologic malignancies, or primary peritoneal surface malignancies such as peritoneal mesothelioma and primary peritoneal adenocarcinoma may be efficiently treated by cytoreductive surgery (CRS) and hyperthermic intraperitoneal chemotherapy (HIPEC) in selected patients. Method: CRS is based ...